Previous 10 | Next 10 |
2024-01-18 13:26:46 ET More on Bausch Health Companies Bausch Health: $20bn Debt Is A Mighty Elephant In The Room Bausch Health Companies Inc. (BHC) Q3 2023 Earnings Call Transcript Bausch Health Companies Inc. 2023 Q3 - Results - Earnings Call Presentation B...
Approval Represents an Important Breakthrough in One of the Largest Medical Aesthetics Markets LAVAL, QC / ACCESSWIRE / January 18, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and Solta Medical, a global leader in the medical aesthetics market, today announced the approval of The...
2024-01-17 03:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-08 13:53:28 ET More on Bausch Health Companies Bausch Health: $20bn Debt Is A Mighty Elephant In The Room Bausch Health Companies Inc. (BHC) Q3 2023 Earnings Call Transcript Bausch Health Companies Inc. 2023 Q3 - Results - Earnings Call Presentation B...
2024-01-08 08:31:17 ET More on Bausch Health, Bausch + Lomb, etc. Bausch Health: $20bn Debt Is A Mighty Elephant In The Room Bausch + Lomb: Not A Good Time To Buy (Rating Downgrade) Bausch Health Companies Inc. (BHC) Q3 2023 Earnings Call Transcript Bausch re...
2023-12-21 12:59:06 ET More on Bausch Health Companies Bausch Health: $20bn Debt Is A Mighty Elephant In The Room Bausch Health Companies Inc. (BHC) Q3 2023 Earnings Call Transcript Bausch Health Companies Inc. 2023 Q3 - Results - Earnings Call Presentation B...
Trial Meets Both Primary and Key Secondary Endpoints LAVAL, QC / ACCESSWIRE / December 21, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") today announced positive topline results from the Company's Phase 2 study evaluating Amiselimod, an investigat...
2023-12-19 22:37:01 ET Summary John Paulson's 13F portfolio value increased by 9% to $1.12 billion this quarter. The top five positions in the portfolio were Horizon Therapeutics, Bausch Health, Brightsphere Investment Group, NovaGold, and Perpetua Resources. Paulson's stake i...
LAVAL, QC / ACCESSWIRE / December 18, 2023 / Bausch Health, Canada, part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), ("Bausch Health" or the "Company") today announced that DUOBRII™ (0.01% w/w halobetasol propionate and 0.045% w/w tazarotene), the company's novel topical prescrip...
2023-12-10 22:56:31 ET Summary Carl Icahn's 13F filing decreased from 15 to 14 holdings this quarter. The top five holdings in the filing are Icahn Enterprises, CVR Energy, Occidental Petroleum warrants, Southwest Gas Holdings, and FirstEnergy. Icahn disposed of his stake in X...
News, Short Squeeze, Breakout and More Instantly...
Bausch Health Companies Inc. Company Name:
BHC Stock Symbol:
NYSE Market:
Bausch Health Companies Inc. Website:
LAVAL, QC / ACCESSWIRE / July 11, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2024 financial results on Thursday, August 1, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business...
2024-07-10 00:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LAVAL, QC / ACCESSWIRE / June 20, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") and its gastroenterology business, Salix Pharmaceuticals, today announced that it has filed a patent infringement lawsuit in the U.S. District Court for the District of Ne...